Hepatic sequestration and modulation of the canalicular transport of the organic cation, daunorubicin, in the Rat

Hepatology. 1999 Feb;29(2):483-93. doi: 10.1002/hep.510290216.


In contrast to organic anions, substrates for the canalicular mdr1a and b are usually organic cations and are often sequestered in high concentrations in intracellular acidic compartments. Because many of these compounds are therapeutic agents, we investigated if their sequestration could be regulated. We used isolated perfused rat liver (IPRL), isolated rat hepatocyte couplets (IRHC), and WIF-B cells to study the cellular localization and biliary excretion of the fluorescent cation, daunorubicin (DNR). Despite rapid (within 15 minutes) and efficient (>90%) cellular uptake in the IPRL, only approximately 10% of the dose administered (0.2-20 micromol) was excreted in bile after 85 minutes. Confocal microscopy revealed fluorescence predominantly in vesicles in the pericanalicular region in IPRL, IRHC, and WIF-B cells. Treatment of these cells with chloroquine and bafilomycin A, agents that disrupt the pH gradient across the vesicular membrane, resulted in a loss of vesicular fluorescence, reversible in the case of bafilomycin A. Taurocholate (TC) and dibutyryl cAMP (DBcAMP), stimulators of transcytotic vesicular transport, increased the biliary recovery of DNR significantly above controls, by 70% and 35%, respectively. The microtubule destabilizer, nocodazole, decreased biliary excretion of DNR. No effect on secretion was noted in TR- mutant rats deficient in mrp2. Coadministration of verapamil, an inhibitor of mdr1, also decreased DNR excretion. While TC and DBcAMP did not affect the fluorescent intensity or pattern of distribution in IRHC, nocodazole resulted in redistribution of DNR to peripheral punctuate structures. These findings suggest that the organic cation, DNR, is largely sequestered in cells such as hepatocytes, yet its excretion can still be modulated.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Antineoplastic Agents
  • Bile / metabolism
  • Bile Canaliculi / metabolism*
  • Biological Transport
  • Bucladesine / pharmacology
  • Cations
  • Chloroquine / pharmacology
  • Daunorubicin / metabolism*
  • Kinetics
  • Liver / metabolism*
  • Macrolides*
  • Male
  • Mitochondrial Proteins*
  • Nocodazole / pharmacology
  • Rats
  • Rats, Wistar
  • Ribosomal Proteins / physiology
  • Saccharomyces cerevisiae Proteins*
  • Taurocholic Acid / pharmacology
  • Verapamil / pharmacology


  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Cations
  • MRP2 protein, S cerevisiae
  • Macrolides
  • Mitochondrial Proteins
  • Ribosomal Proteins
  • Saccharomyces cerevisiae Proteins
  • bafilomycin A
  • Taurocholic Acid
  • Bucladesine
  • Chloroquine
  • Verapamil
  • Nocodazole
  • Daunorubicin